Our data also showed that HMGB3 suppression reduces the expression of major downstream target genes of the MAPK/ERK signaling pathway, including ETS-1, CCND1, and c-Myc, which have key roles in ovarian cancer occurrence and development. The gene discussed is CCND1; the disease is ovarian cancer.